Glaxosmithkline: Ethics and Critical Thinking
Sam Hite
Legal Environment of Business
3 April 2013
McClellan
GlaxoSmithKline: Ethics and Clinical Thinking GlaxoSmithKline (GSK) is known around the world for many of its home health products and a good number of the prescription drugs that are in our medicine cabinets. GSK is a global healthcare company. They focus on the discovery, development, manufacturing, and marketing of pharmaceutical and consumer health-related products.
A brief history of the company, according to the Marketline report GlaxoSmithKline: Through Mergers and acquisitions to success, begins with a man named Joseph Nathan who founded a company called Glaxo in 1873 as a general trading company that first manufactured a vitamin D supplement called Ostelin in 1924. Glaxo entered the US pharmaceutical market in 1978, and acquired a smaller company – Wellcome – in 1995.
John K. Smith opened his first drugstore in 1830 to grow into what was called Smith, Kline & Company in 1875 after which merged with Beecham Research Laboratories, and formed SmithKline Beecham in 1989. (Marketline) Glaxo Wellcome and SmithKline Beecham finally merged together in 2000 to form the global health care giant GlaxoSmithKline.
GSK has a wide reaching global presence with offices in 115 countries worldwide focusing on three primary areas of business: pharmaceuticals, vaccines, and consumer health care. Their products are used by millions of people around the world, helping them to do more, feel better and live longer. Currently GSK provides 90 different pharmaceuticals either directly to the market or in different stages of testing, 25 vaccines, and 57 OTC consumer health products. Many familiar products include Aquafresh® toothpaste, Breathe Right® strips, and Sensodyne®.
In addition, GSK spends over $6 billion per year in research developing new products for just the pharmaceutical business. In fact, GSK is the world’s largest research and development spender. According to GlaxoSmithKline’s
Legal Environment of Business
3 April 2013
McClellan
GlaxoSmithKline: Ethics and Clinical Thinking GlaxoSmithKline (GSK) is known around the world for many of its home health products and a good number of the prescription drugs that are in our medicine cabinets. GSK is a global healthcare company. They focus on the discovery, development, manufacturing, and marketing of pharmaceutical and consumer health-related products.
A brief history of the company, according to the Marketline report GlaxoSmithKline: Through Mergers and acquisitions to success, begins with a man named Joseph Nathan who founded a company called Glaxo in 1873 as a general trading company that first manufactured a vitamin D supplement called Ostelin in 1924. Glaxo entered the US pharmaceutical market in 1978, and acquired a smaller company – Wellcome – in 1995.
John K. Smith opened his first drugstore in 1830 to grow into what was called Smith, Kline & Company in 1875 after which merged with Beecham Research Laboratories, and formed SmithKline Beecham in 1989. (Marketline) Glaxo Wellcome and SmithKline Beecham finally merged together in 2000 to form the global health care giant GlaxoSmithKline.
GSK has a wide reaching global presence with offices in 115 countries worldwide focusing on three primary areas of business: pharmaceuticals, vaccines, and consumer health care. Their products are used by millions of people around the world, helping them to do more, feel better and live longer. Currently GSK provides 90 different pharmaceuticals either directly to the market or in different stages of testing, 25 vaccines, and 57 OTC consumer health products. Many familiar products include Aquafresh® toothpaste, Breathe Right® strips, and Sensodyne®.
In addition, GSK spends over $6 billion per year in research developing new products for just the pharmaceutical business. In fact, GSK is the world’s largest research and development spender. According to GlaxoSmithKline’s